These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8108962)

  • 1. Greater than 18-year follow-up after cardiac transplantation: clinical report and pathological findings.
    Henry E; Montiès JR; Mouly-Bandini A; Goudard A; Blin D; Mesana T; Avierinos C; Choux R; Gros N
    Transplant Proc; 1994 Feb; 26(1):249. PubMed ID: 8108962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignomas after transplantation of thoracic organs].
    Stempfle HU
    Dtsch Med Wochenschr; 1998 Jan; 123(1-2):26-9. PubMed ID: 9465853
    [No Abstract]   [Full Text] [Related]  

  • 3. An exceptional 18-year follow-up after cardiac transplantation. How can malignancies occur during immunosuppressive therapy?
    Xerri L; Payan MJ; Choux R; Gros N; Hassoun J; Chamlian A; Blin D; Monties JR
    Cancer; 1989 May; 63(9):1697-9. PubMed ID: 2649224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukaemic mycosis fungoides in an atomic bomb survivor with lung and renal cancers.
    Shimauchi T; Nishio D; Isoda H; Sugita K; Kabashima K; Tokura Y
    Clin Exp Dermatol; 2009 Oct; 34(7):e322-4. PubMed ID: 19456778
    [No Abstract]   [Full Text] [Related]  

  • 5. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Brann WM; Bennett LE; Keck BM; Hosenpud JD
    J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of cancer as a complication of clinical transplantation.
    Penn I
    Transplant Proc; 1977 Mar; 9(1):1121-7. PubMed ID: 325738
    [No Abstract]   [Full Text] [Related]  

  • 7. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of malignancy after transplantation in Chinese heart allograft recipients.
    Hsu RB; Chen RJ; Chou NK; Ko WJ; Wang SS; Chu SH
    Transpl Int; 2005 Mar; 18(3):283-8. PubMed ID: 15730487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors after renal and cardiac transplantation.
    Penn I
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):431-45. PubMed ID: 8468275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer after heart transplantation: a 17-year experience.
    Potaris K; Radovancevic B; Thomas CD; Gregoric I; Vaporciyan AA; Riggs SA; Radovancevic R; Vaughn WK; Frazier OH
    Ann Thorac Surg; 2005 Mar; 79(3):980-3. PubMed ID: 15734418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous and basal cell carcinoma in heart transplant recipients.
    Lampros TD; Cobanoglu A; Parker F; Ratkovec R; Norman DJ; Hershberger R
    J Heart Lung Transplant; 1998 Jun; 17(6):586-91. PubMed ID: 9662094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
    Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
    Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo solid malignancies after cardiac transplantation.
    Goldstein DJ; Williams DL; Oz MC; Weinberg AD; Rose EA; Michler RE
    Ann Thorac Surg; 1995 Dec; 60(6):1783-9. PubMed ID: 8787481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant neoplasms after organ transplantation].
    Mol'kov IuN; Golikova SD; Balakirev EM
    Vopr Onkol; 1980; 26(11):107-13. PubMed ID: 7006209
    [No Abstract]   [Full Text] [Related]  

  • 18. Solid tumors after heart transplantation: lethality of lung cancer.
    Pham SM; Kormos RL; Landreneau RJ; Kawai A; Gonzalez-Cancel I; Hardesty RL; Hattler BG; Griffith BP
    Ann Thorac Surg; 1995 Dec; 60(6):1623-6. PubMed ID: 8787454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of rapamycin slows progression of cardiac transplantation vasculopathy.
    Mancini D; Pinney S; Burkhoff D; LaManca J; Itescu S; Burke E; Edwards N; Oz M; Marks AR
    Circulation; 2003 Jul; 108(1):48-53. PubMed ID: 12742978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
    Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
    Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.